Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03179956
Title Impact of Ribociclib on Head and Neck Squamous Cell Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

oral cavity cancer

oropharynx cancer

larynx cancer

Therapies

Ribociclib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.